Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature

BACKGROUND: Zoledronic acid is an intravenous, highly potent aminobisphosphonate for use in patients with primary or secondary osteoporosis. Zoledronic acid-induced prolonged side-effects are well known and quite common. However, severe side-effects can be a threat to life. We report a case of sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmi-Lüthje, Ilona, Lüthje, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754987/
https://www.ncbi.nlm.nih.gov/pubmed/36522673
http://dx.doi.org/10.1186/s13256-022-03695-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754987/
https://www.ncbi.nlm.nih.gov/pubmed/36522673
http://dx.doi.org/10.1186/s13256-022-03695-y

Ejemplares similares